Dr Reddy's Laboratories Ltd

Common Name
Dr Reddy's Laboratories
Country
India
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
27,811
Ticker
DRREDDY
Exchange
NATIONAL STOCK EXCHANGE OF INDIA
Description
Dr. Reddy's Laboratories Ltd. is a globally recognized pharmaceutical company specializing in the manufacturing and distribution of a wide array of therapeutic substances and active pharmaceutical ing...

Dr Reddy's Laboratories's Climate Target Data Preview

As of 2024, Dr Reddy's Laboratories has disclosed 3 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 2 absolute reduction targets and 1 intensity-based target target, signaling the company’s commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into Dr Reddy's Laboratories ’s climate strategy, ambition level, and alignment with global decarbonization goals.

Target TypeScope of TargetUnitTargetTarget Year
Absolute-based Target
Scope 3 - Total Upstream (Cat. 1+2+3+4+5+6+7+8), Scope 3 - Downstream Transportation and Distribution (Cat. 9), Scope 3 - Processing of Sold Products (Cat. 10), Scope 3 - End-of-Life Treatment of Sold Products (Cat. 12), Scope 3 - Downstream Leased Assets (Cat. 13)
Metric Tonnes of CO2 equivalent (mtCO2e)
Copy restricted. Please purchase to unlock this data.
2030
Absolute-based Target
Scope 1 - Total, Scope 2 - Total
Metric Tonnes of CO2 equivalent (mtCO2e)
Copy restricted. Please purchase to unlock this data.
2031
Intensity-based Target
Scope 1 - Total, Scope 2 - Total
Metric Tonnes of CO2 equivalent (mtCO2e) per US Dollar (USD) of Revenue
Copy restricted. Please purchase to unlock this data.
2031

This table provides a simplified preview of selected climate targets data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.

Insights into Dr Reddy's Laboratories's Greenhouse Gas Emissions Pathways

As of 2024, Dr Reddy's Laboratories has set greenhouse gas (GHG) emissions reduction targets that cover both its operational emissions (Scope 1 and 2) and value chain emissions (Scope 3), offering a comprehensive view of its total carbon footprint.

Does Dr Reddy's Laboratories have a target to reduce the emissions from its operations?

As of 2024, Dr Reddy's Laboratories has set a target to reduce its operational greenhouse gas (GHG) emissions, specifically those from Scope 1 and Scope 2 sources.

Dr Reddy's Laboratories's most ambitious operational target is to reduce these emissions by 50.2% by 2031, compared to a baseline of 0 Metric Tonnes of CO2 equivalent (mtCO2e) per US Dollar (USD) of Revenue in 2021.

Dr Reddy's Laboratories has already surpassed its operational emissions reduction target, with 2024 levels falling below the 2031 value, achieving its climate goal ahead of schedule.

Dr Reddy's Laboratories's Operational (Scope 1+2) Emissions Pathway

20212024203100000BaselineCurrent (-55%)

Does Dr Reddy's Laboratories have a target to reduce the emissions from its value chain?

As of 2024, Dr Reddy's Laboratories has set a target to reduce its value chain greenhouse gas (GHG) emissions, covering 5 out of the 15 Scope 3 categories defined by the GHG Protocol.

Dr Reddy's Laboratories's most ambitious value chain target is to reduce these emissions by 12.5% by 2030, compared to a baseline of 920,609.114 Metric Tonnes of CO2 equivalent (mtCO2e) in 2022.

As of 2024, Dr Reddy's Laboratories is ahead of schedule on its value chain emissions reduction target, having achieved 46.56% of the planned reduction.

Dr Reddy's Laboratories's Value Chain (Scope 3) Emissions Pathway

2022202420300250 k500 k750 k1 MCurrent (-6%)
Want Full Access to Dr Reddy's Laboratories's Climate Targets Dataset?
Sign Up